No Detail Found!

Clinical Study on Ulinastatin Combined with Ambroxol in the Treatment of AECOPD Complicated with Type II Respiratory Failure

Author(s)
Xia Li Emergency Internal Medicine Department of Weihai Central Hospital,Weihai, 264400,China
Xueliang Zhan Emergency Internal Medicine Department of Weihai Central Hospital,Weihai, 264400,China
Xinjie Shi Department of Respiratory Medicine, Weihai Central Hospital,Weihai, 264400,China
Abstract
The Objective of the present study was to observe and analyze the efficacy of ulinastatin combined with ambroxol in the treatment of AECOPD complicated with type II respiratory failure. A total of 180 patients treated in our hospital due to AECOPD complicated with type II respiratory failure were enrolled in the study and divided into study group and reference group, each with 90 patients. The study group was treated with ulinastatin and ambroxol, while general routine treatment was implemented in the reference group. The treatment outcomes were compared between the two groups. The blood content levels of WBC, CRP and PCT were compared between the two groups after one week of treatment. The results showed that the improvement effect was significantly superior in the study group, p<0.05. The arterial blood gas analysis showed that the arterial blood PO2 was elevated and PCO2 was decreased in the study group. The difference was statistically significant (P<0.05). It was concluded that the application of ulinastatin combined with ambroxol in the treatment of AECOPD complicated with type II respiratory failure can significantly improve the treatment effect, help patients actively improve the condition and promote body recovery as soon as possible.
Publication Details
Page(s) 367-370
Published Journal: Pakistan Journal of Zoology, Volume: 53, Issue: 1, Year: 2021

Request the full text from PASTIC

Keywords
AECOPD complicated with type II respiratory failure, Ambroxol, Combination therapy, Ulinastatin, Therapeutic effect
0

Citations

0

Downloads

67

Views